Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells
Authors:
- Wei WeiWWWei Wei
- Wu-Yi SunWSWu-Yi Sun
- Xiang LiXLXiang Li
- 1 April 2009
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 122 (3) , 502-508
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effects of Astragalus Polysaccharides and Astragalosides on the Phagocytosis of Mycobacterium tuberculosis by MacrophagesJournal of International Medical Research, 2007
- Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF‐β as major players and therapeutic targetsJournal of Cellular and Molecular Medicine, 2006
- Stellate cells: A moving target in hepatic fibrogenesis†Hepatology, 2004
- Liver extracellular matrix in health and diseaseThe Journal of Pathology, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferationHepatology, 1999
- Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum‐induced rat liver fibrosisPathology International, 1994
- Experimental Models of Hepatic Fibrosis: A ReviewSeminars in Liver Disease, 1990
- Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.Journal of Clinical Investigation, 1989
- Differential effects of interleukin‐1α, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat‐storing cellsLiver International, 1989